Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja BFI Finance Indonesia Tbk (BFIN) vs Tempo Scan Pacific Tbk. (TSPC)

BFI Finance Indonesia TbkTrading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan BFI Finance Indonesia Tbk dan Tempo Scan Pacific Tbk.: BFI Finance Indonesia Tbk diperdagangkan di Rp785 (kapitalisasi pasar 12,03 T, volume 24 jam 12,2 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.500 (kapitalisasi pasar 11,36 T, volume 24 jam 200 rb). Perbedaan utamanya: BFI Finance Indonesia Tbk dan Tempo Scan Pacific Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan BFI Finance Indonesia Tbk lebih aktif diperdagangkan (12,2 jt vs 200 rb). Mana yang lebih baik tergantung tujuan investasimu.

BFINTSPC
Kapitalisasi Pasar
12,03 T11,36 T
Volume
12,2 jt200 rb
Lot
122 rb2 rb
Perputaran
9,55 M500,06 jt
Harga Rata-rata
782,932.500,28
Nilai Transaksi
9,55 M500,06 jt
Harga Ekuilibrium Indikatif
7852.500
Volume Ekuilibrium Indikatif
5,52 rb100

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BFIN
Lihat detail
TSPC
Lihat detail

Tentang BFI Finance Indonesia Tbk

PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001

Selengkapnya di halaman BFIN

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC